Article Text
Editorial
Why should we screen for atrial fibrillation?
Statistics from Altmetric.com
Footnotes
Contributors ES and JE contributed equally to this manuscript.
Competing interests ES has received lecture fees from MSD, Bristol-Myers Squibb-Pfizer, Boehringer-Ingelheim and Sanofi and a research grant from Boehringer-Ingelheim. JE has received consultancy fees from Sanofi and Pfizer, lecture fees from Astra Zeneca, Boehringer-Ingelheim, Medtronic and Bristol-Myers Squibb and travel expenses from Boehringer-Ingelheim and Sanofi.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- Arrhythmias and sudden death
- Heartbeat